- Home
- FLWS vs GLUE Comparison
FLWS vs GLUE Comparison
Compare FLWS & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLWS
- GLUE
- Stock Information
- Founded
- FLWS 1976
- GLUE 2019
- Country
- FLWS United States
- GLUE United States
- Employees
- FLWS N/A
- GLUE N/A
- Industry
- FLWS Other Specialty Stores
- GLUE Biotechnology: Pharmaceutical Preparations
- Sector
- FLWS Consumer Discretionary
- GLUE Health Care
- Exchange
- FLWS Nasdaq
- GLUE Nasdaq
- Market Cap
- FLWS 347.1M
- GLUE 351.2M
- IPO Year
- FLWS 1999
- GLUE 2021
- Fundamental
- Price
- FLWS $5.60
- GLUE $4.80
- Analyst Decision
- FLWS Hold
- GLUE Buy
- Analyst Count
- FLWS 1
- GLUE 2
- Target Price
- FLWS $7.50
- GLUE $13.50
- AVG Volume (30 Days)
- FLWS 349.6K
- GLUE 369.2K
- Earning Date
- FLWS 10-30-2025
- GLUE 08-07-2025
- Dividend Yield
- FLWS N/A
- GLUE N/A
- EPS Growth
- FLWS N/A
- GLUE N/A
- EPS
- FLWS N/A
- GLUE 0.29
- Revenue
- FLWS $1,709,948,000.00
- GLUE $177,986,000.00
- Revenue This Year
- FLWS N/A
- GLUE $83.76
- Revenue Next Year
- FLWS N/A
- GLUE N/A
- P/E Ratio
- FLWS N/A
- GLUE $16.32
- Revenue Growth
- FLWS N/A
- GLUE 2990.57
- 52 Week Low
- FLWS $3.86
- GLUE $3.50
- 52 Week High
- FLWS $9.24
- GLUE $12.40
- Technical
- Relative Strength Index (RSI)
- FLWS 50.17
- GLUE 51.69
- Support Level
- FLWS $5.37
- GLUE $4.54
- Resistance Level
- FLWS $5.58
- GLUE $4.93
- Average True Range (ATR)
- FLWS 0.22
- GLUE 0.21
- MACD
- FLWS 0.00
- GLUE 0.06
- Stochastic Oscillator
- FLWS 63.49
- GLUE 81.43
About FLWS 1-800-FLOWERS.COM Inc.
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.
About GLUE Monte Rosa Therapeutics Inc.
Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.